We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.57%
This Fund
S&P 500
This Quarter
Est. Return
+13.98%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
–
AUM
$28.2B
AUM Growth
+$448M
(+1.6%)
Cap. Flow
-$1.83B
Cap. Flow
% of AUM
-6.51%
Top 10 Holdings %
Top 10 Hldgs %
26.53%
Holding
1,544
New
202
Increased
554
Reduced
583
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$407M |
| 2 |
Apple
AAPL
|
+$286M |
| 3 |
NVIDIA
NVDA
|
+$283M |
| 4 |
Netflix
NFLX
|
+$207M |
| 5 |
Pfizer
PFE
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$461M |
| 3 |
Walt Disney
DIS
|
+$227M |
| 4 |
Chevron
CVX
|
+$225M |
| 5 |
ExxonMobil
XOM
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.74% |
| 2 | Healthcare | 16.27% |
| 3 | Consumer Discretionary | 14.2% |
| 4 | Communication Services | 10.23% |
| 5 | Financials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Aldeyra Therapeutics
ALDX
$86.9M
| $6.41M | 0.02% |
645,020
| – | – |
|
502
Triumph Financial Inc
TFIN
$1.87B
| $6.39M | 0.02% |
110,044
+37,608
| +52% | +$2.16M |
|
503
ITT
ITT
$19.4B
| $6.38M | 0.02% |
73,958
-52,764
| -42% | -$4.64M |
|
504
Capitol Federal Financial
CFFN
$1.09B
| $6.37M | 0.02% |
945,815
+667,321
| +240% | +$5.42M |
|
505
LiveRamp
RAMP
$2.31B
| $6.35M | 0.02% |
289,594
+131,129
| +83% | +$3.13M |
|
506
Analog Devices
ADI
$186B
| $6.34M | 0.02% |
32,162
-23,100
| -42% | -$4.14M |
|
507
Amphastar Pharmaceuticals
AMPH
$858M
| $6.34M | 0.02% |
169,056
-4,423
| -3% | -$145K |
|
508
Ametek
AME
$58.7B
| $6.34M | 0.02% |
43,610
-295,272
| -87% | -$42M |
|
509
Customers Bancorp
CUBI
$2.82B
| $6.34M | 0.02% |
342,123
+150,341
| +78% | +$4.1M |
|
510
PENN Entertainment
PENN
$2.53B
| $6.34M | 0.02% |
+213,600
| New | +$6.62M |
|
511
Bristol-Myers Squibb
BMY
$132B
| $6.32M | 0.02% |
91,115
+5,406
| +6% | +$381K |
|
|
GMS
512
DELISTED
GMS Inc
GMS
| $6.31M | 0.02% |
109,086
+33,053
| +43% | +$1.87M |
|
513
Wabtec
WAB
$50.3B
| $6.31M | 0.02% |
62,483
+27,885
| +81% | +$2.85M |
|
514
Nordson
NDSN
$17.3B
| $6.3M | 0.02% |
28,361
+23,805
| +522% | +$5.45M |
|
|
RVNC
515
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.28M | 0.02% |
194,911
+2,552
| +1% | +$79.6K |
|
516
Collegium Pharmaceutical
COLL
$913M
| $6.21M | 0.02% |
258,690
+125,956
| +95% | +$3.34M |
|
517
Green Dot
GDOT
$770M
| $6.2M | 0.02% |
361,136
-244,542
| -40% | -$4.27M |
|
518
Pacira BioSciences
PCRX
$924M
| $6.2M | 0.02% |
+151,824
| New | +$6.04M |
|
519
Comcast
CMCSA
$92.9B
| $6.19M | 0.02% |
163,222
+46,006
| +39% | +$1.74M |
|
520
Guidewire Software
GWRE
$15.2B
| $6.16M | 0.02% |
75,088
+53,953
| +255% | +$3.92M |
|
521
Enviri
NVRI
$564M
| $6.14M | 0.02% |
898,253
+730,732
| +436% | +$5.5M |
|
522
HealthStream
HSTM
$849M
| $6.12M | 0.02% |
225,815
+189,604
| +524% | +$4.73M |
|
523
CBIZ
CBZ
$2.96B
| $6.09M | 0.02% |
123,110
-13,433
| -10% | -$647K |
|
524
Roku
ROKU
$22.9B
| $6.08M | 0.02% |
+92,387
| New | +$5.41M |
|
525
Xylem
XYL
$28.1B
| $6.01M | 0.02% |
57,401
+44,992
| +363% | +$4.7M |
|
Similar funds
BC
Assenagon Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Assenagon Asset Management held 1,544 positions worth $28.2B, up 1.6% from $27.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Assenagon Asset Management withdrew a net $1.83B in Q1 2023, closing 146 positions and reducing 583 holdings. Its most notable exit was TSMC, an estimated $198M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Assenagon Asset Management opened a new position in Azenta worth $35.2M.
- Assenagon Asset Management's largest Q1 2023 buy was Azenta: 788,927 shares worth $35.2M.
- Assenagon Asset Management added most to Pinduoduo in Q1 2023, an estimated $407M increase.
- Assenagon Asset Management's biggest Q1 2023 reduction was Microsoft, cutting an estimated $524M.
- Assenagon Asset Management fully exited TSMC in Q1 2023, selling an estimated $198M.
- Assenagon Asset Management's ten largest holdings make up 27% of its $28.2B portfolio in Q1 2023.
- Assenagon Asset Management opened 202 new positions and closed 146 in Q1 2023.
- Assenagon Asset Management's portfolio value rose 1.6% quarter-over-quarter to $28.2B.
Based on Assenagon Asset Management's 13F filing for Q1 2023, filed 18 Apr 2023.